Dompe

Dompe is an Italian biopharmaceutical company focused on innovation, where a long-standing tradition in personal health complements its commitment to research and development to address unmet therapeutic needs to date. Dompe's primary care products are sold in more than 10,000 pharmacies in Italy, mainly engaged in the development and sale of pharmaceuticals, adjuvants, medical devices, and cosmetics, as well as areas involving vitamins, mineral supplements, and personal hygiene. Therapeutic fields include cardiovascular, gastrointestinal, pediatrics, neurology, urology, ophthalmology, oral medicine, and ventilators. Dompe currently sells 50 million units of medication in approximately 40 countries worldwide. The biotechnology division focuses on rare diseases, such as ophthalmology, where the company has developed and marketed the first ophthalmic product based on rhNGF (a molecule discovered by Nobel laureate Levi-Montalcini) for the treatment of patients with neurotrophic keratitis.